House of Lords Business
Show full summary

Lord Freyberg to ask Her Majesty's Government what assessment the Chief Scientific Adviser has made of the importance of molecular testing to drive modern cancer trial recruitment, and of the introduction of such testing for which cancers offer the most value to the UK in terms of driving clinical trial recruitment.  HL11502

Question HL11502: tabled on 14 November 2018 and due for answer by 28 November 2018

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Freyberg to ask Her Majesty's Government what assessment the Chief Scientific Adviser has made of the importance of molecular testing to drive modern cancer trial recruitment, and of the introduction of such testing for which cancers offer the most value to the UK in terms of driving clinical trial recruitment.  HL11502
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Freyberg
Crossbench
Excepted Hereditary